Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-08-21

FDA Approved: PEMETREXED — Original Application (Teva Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved Teva Pharmaceuticals' original application for pemetrexed, a chemotherapy agent indicated for non-small cell lung cancer and malignant pleural …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pemetrexed (pemetrexed)

Snippet

ORIG AP for PEMETREXED (PEMETREXED)